Summer S Han1,2,3, Eric Chow1, Kevin Ten Haaf4, Iakovos Toumazis5,6, Pianpian Cao7, Mehrad Bastani5,6, Martin Tammemagi8, Jihyoun Jeon7, Eric J Feuer9, Rafael Meza7, Sylvia K Plevritis2,5,6. 1. Quantitative Sciences Unit, Department of Medicine, Stanford University, Stanford, CA, USA. 2. Stanford Cancer Institute, Stanford University, Stanford, CA, USA. 3. Department of Neurosurgery, Stanford University, Stanford, CA, USA. 4. Erasmus Medical Center, Rotterdam, Netherlands. 5. Department of Biomedical Data Sciences, Stanford University, Stanford, CA, USA. 6. Department of Radiology, Stanford University, Stanford, CA, USA. 7. Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA. 8. Brock University, Ontario, Canada. 9. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Abstract
BACKGROUND: Current US Preventive Services Task Force (USPSTF) lung cancer screening guidelines are based on smoking history and age (55-80 years). These guidelines may miss those at higher risk, even at lower exposures of smoking or younger ages, because of other risk factors such as race, family history, or comorbidity. In this study, we characterized the demographic and clinical profiles of those selected by risk-based screening criteria but were missed by USPSTF guidelines in younger (50-54 years) and older (71-80 years) age groups. METHODS: We used data from the National Health Interview Survey, the CISNET Smoking History Generator, and results of logistic prediction models to simulate lifetime lung cancer risk-factor data for 100 000 individuals in the 1950-1960 birth cohorts. We calculated age-specific 6-year lung cancer risk for each individual from ages 50 to 90 years using the PLCOm2012 model and evaluated age-specific screening eligibility by USPSTF guidelines and by risk-based criteria (varying thresholds between 1.3% and 2.5%). RESULTS: In the 1950 birth cohort, 5.4% would have been ineligible for screening by USPSTF criteria in their younger ages but eligible based on risk-based criteria. Similarly, 10.4% of the cohort would be ineligible for screening by USPSTF in older ages. Notably, high proportions of blacks were ineligible for screening by USPSTF criteria at younger (15.6%) and older (14.2%) ages, which were statistically significantly greater than those of whites (4.8% and 10.8%, respectively; P < .001). Similar results were observed with other risk thresholds and for the 1960 cohort. CONCLUSIONS: Further consideration is needed to incorporate comprehensive risk factors, including race and ethnicity, into lung cancer screening to reduce potential racial disparities.
BACKGROUND: Current US Preventive Services Task Force (USPSTF) lung cancer screening guidelines are based on smoking history and age (55-80 years). These guidelines may miss those at higher risk, even at lower exposures of smoking or younger ages, because of other risk factors such as race, family history, or comorbidity. In this study, we characterized the demographic and clinical profiles of those selected by risk-based screening criteria but were missed by USPSTF guidelines in younger (50-54 years) and older (71-80 years) age groups. METHODS: We used data from the National Health Interview Survey, the CISNET Smoking History Generator, and results of logistic prediction models to simulate lifetime lung cancer risk-factor data for 100 000 individuals in the 1950-1960 birth cohorts. We calculated age-specific 6-year lung cancer risk for each individual from ages 50 to 90 years using the PLCOm2012 model and evaluated age-specific screening eligibility by USPSTF guidelines and by risk-based criteria (varying thresholds between 1.3% and 2.5%). RESULTS: In the 1950 birth cohort, 5.4% would have been ineligible for screening by USPSTF criteria in their younger ages but eligible based on risk-based criteria. Similarly, 10.4% of the cohort would be ineligible for screening by USPSTF in older ages. Notably, high proportions of blacks were ineligible for screening by USPSTF criteria at younger (15.6%) and older (14.2%) ages, which were statistically significantly greater than those of whites (4.8% and 10.8%, respectively; P < .001). Similar results were observed with other risk thresholds and for the 1960 cohort. CONCLUSIONS: Further consideration is needed to incorporate comprehensive risk factors, including race and ethnicity, into lung cancer screening to reduce potential racial disparities.
Authors: Chien-Ching Li; Alicia K Matthews; Mantle M Rywant; Emily Hallgren; Raj C Shah Journal: Cancer Causes Control Date: 2018-10-30 Impact factor: 2.506
Authors: Martin M Oken; Willam G Hocking; Paul A Kvale; Gerald L Andriole; Saundra S Buys; Timothy R Church; E David Crawford; Mona N Fouad; Claudine Isaacs; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Joshua M Rathmell; Thomas L Riley; Patrick Wright; Neil Caparaso; Ping Hu; Grant Izmirlian; Paul F Pinsky; Philip C Prorok; Barnett S Kramer; Anthony B Miller; John K Gohagan; Christine D Berg Journal: JAMA Date: 2011-10-26 Impact factor: 56.272
Authors: Srinadh Annangi; Snigdha Nutalapati; Marilyn G Foreman; Rathi Pillai; Eric L Flenaugh Journal: J Racial Ethn Health Disparities Date: 2018-05-04
Authors: Martin C Tammemagi; Heidi Schmidt; Simon Martel; Annette McWilliams; John R Goffin; Michael R Johnston; Garth Nicholas; Alain Tremblay; Rick Bhatia; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; David M Hwang; Francis Laberge; Michel Gingras; Sergio Pasian; Christian Couture; John R Mayo; Paola V Nasute Fauerbach; Sukhinder Atkar-Khattra; Stuart J Peacock; Sonya Cressman; Diana Ionescu; John C English; Richard J Finley; John Yee; Serge Puksa; Lori Stewart; Scott Tsai; Ehsan Haider; Colm Boylan; Jean-Claude Cutz; Daria Manos; Zhaolin Xu; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Harmanjatinder S Sekhon; Paul Burrowes; Paul MacEachern; Stefan Urbanski; Don D Sin; Wan C Tan; Natasha B Leighl; Frances A Shepherd; William K Evans; Ming-Sound Tsao; Stephen Lam Journal: Lancet Oncol Date: 2017-10-18 Impact factor: 41.316
Authors: Harry J de Koning; Rafael Meza; Sylvia K Plevritis; Kevin ten Haaf; Vidit N Munshi; Jihyoun Jeon; Saadet Ayca Erdogan; Chung Yin Kong; Summer S Han; Joost van Rosmalen; Sung Eun Choi; Paul F Pinsky; Amy Berrington de Gonzalez; Christine D Berg; William C Black; Martin C Tammemägi; William D Hazelton; Eric J Feuer; Pamela M McMahon Journal: Ann Intern Med Date: 2014-03-04 Impact factor: 25.391
Authors: Martin C Tammemägi; Timothy R Church; William G Hocking; Gerard A Silvestri; Paul A Kvale; Thomas L Riley; John Commins; Christine D Berg Journal: PLoS Med Date: 2014-12-02 Impact factor: 11.069
Authors: Kevin Ten Haaf; Mehrad Bastani; Pianpian Cao; Jihyoun Jeon; Iakovos Toumazis; Summer S Han; Sylvia K Plevritis; Erik F Blom; Chung Yin Kong; Martin C Tammemägi; Eric J Feuer; Rafael Meza; Harry J de Koning Journal: J Natl Cancer Inst Date: 2020-05-01 Impact factor: 13.506
Authors: Randi M Williams; Tengfei Li; George Luta; Min Qi Wang; Lucile Adams-Campbell; Rafael Meza; Martin C Tammemägi; Kathryn L Taylor Journal: Cancer Date: 2022-02-24 Impact factor: 6.860
Authors: Iakovos Toumazis; Koen de Nijs; Pianpian Cao; Mehrad Bastani; Vidit Munshi; Kevin Ten Haaf; Jihyoun Jeon; G Scott Gazelle; Eric J Feuer; Harry J de Koning; Rafael Meza; Chung Yin Kong; Summer S Han; Sylvia K Plevritis Journal: JAMA Oncol Date: 2021-12-01 Impact factor: 33.006
Authors: Jacqueline V Aredo; Eunji Choi; Victoria Y Ding; Martin C Tammemägi; Kevin Ten Haaf; Sophia J Luo; Neal D Freedman; Lynne R Wilkens; Loïc Le Marchand; Heather A Wakelee; Rafael Meza; Sung-Shim Lani Park; Iona Cheng; Summer S Han Journal: JNCI Cancer Spectr Date: 2022-05-02
Authors: Rafael Meza; Jihyoun Jeon; Iakovos Toumazis; Kevin Ten Haaf; Pianpian Cao; Mehrad Bastani; Summer S Han; Erik F Blom; Daniel E Jonas; Eric J Feuer; Sylvia K Plevritis; Harry J de Koning; Chung Yin Kong Journal: JAMA Date: 2021-03-09 Impact factor: 157.335
Authors: Raymond U Osarogiagbon; Wei Liao; Nicholas R Faris; Meghan Meadows-Taylor; Carrie Fehnel; Jordan Lane; Sara C Williams; Anita A Patel; Olawale A Akinbobola; Alicia Pacheco; Amanda Epperson; Joy Luttrell; Denise McCoy; Laura McHugh; Raymond Signore; Anna M Bishop; Keith Tonkin; Robert Optican; Jeffrey Wright; Todd Robbins; Meredith A Ray; Matthew P Smeltzer Journal: J Clin Oncol Date: 2022-03-08 Impact factor: 50.717